TEVA Stock Predictions
| Recent TEVA Stock Price | TEVA Stock Predictions | |
| $21.79 |  +17.03% |
$25.50 |
| Recent TEVA Analyst Ratings Breakdown, Making TEVA Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 7 | 7 | 7 | 7 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 1 | 1 | 1 | 1 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.25 | 1.25 | 1.25 | 1.25 |
For the TEVA stock predictions from the analysts covering Teva Pharmaceutical Industries Ltd, we have collected all of the individual TEVA stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 6 different analysts covering TEVA (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since TEVA stock predictions may vary widely, another useful metric to consider is the median TEVA stock prediction, which represents the price at which half of the analysts
made TEVA stock predictions that were higher and half made TEVA stock predictions that were lower. This makes for a different take on the TEVA stock predictions out there, as compared to average or mean.
And that median across all the individual TEVA stock predictions was: $27.0 as of 2025-01-24.
The very highest of the TEVA stock predictions for one year price target was $30.0, while the very lowest of the TEVA stock predictions in the analyst group was
$18.0 (with a standard deviation of $4.37). Get the latest Zacks research report on TEVA — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• EQ Stock Predictions
• PTCT Stock Predictions
• VC Stock Predictions
• NERV Stock Predictions
• TEN Stock Predictions
• AUB Stock Predictions
• BTAI Stock Predictions
• TRUP Stock Predictions
• SEAS Stock Predictions
|
|||||||||
|
|
|
|
|
|
Free TEVA Email Alerts:
Avg. Broker Rec.
 
|
Strong Buy (3.75 out of 4) 72nd percentile
(ranked higher than approx. 72% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
